Skip to content
Home/Companies/Biotech/Vincere Biosciences

Vincere Biosciences

Biotech·United States·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Vincere Biosciences?

Vincere Biosciences is an American Biotech company, currently owned by Oscar & Paul (Beiersdorf Venture Capital) since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Oscar & Paul (Beiersdorf Venture Capital)
Investor
Oscar & Paul (Beiersdorf Venture Capital)
Oscar & Paul Venture Capital Fund I · 2020 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Oscar & Paul Venture Capital Fund I

Other portfolio companies in the same fund.

Turbine
Turbine
Active
Deep TechUK· 2026
Cellvie
Cellvie
Active
BiotechUS· 2025
Melt&Marble
Active
BiotechSweden· 2025
ReVentas
Active
ClimateTechUK· 2025
DeepLife
Active
BiotechFrance· 2024
Evommune
Evommune
Exited 2025
BiotechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Vincere Biosciences?

Vincere Biosciences is currently owned by Oscar & Paul (Beiersdorf Venture Capital), through Oscar & Paul Venture Capital Fund I, since 2025.

When did Oscar & Paul (Beiersdorf Venture Capital) acquire Vincere Biosciences?

Oscar & Paul (Beiersdorf Venture Capital) acquired Vincere Biosciences in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue